sulindac

DRUG19 trials

Conditions

Aberrant Crypt FociAcute Myeloid LeukemiaAdenomatous Polyposis ColiBenign NeoplasmsBreast CancerCancerColon CancerColorectal Adenocarcinoma

Phase 1

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

CompletedNCT00245024

National Cancer Institute (NCI)Breast Cancer

Start: 2005-11-30End: 2010-01-31Target: 30Updated: 2013-05-03

Phase 2

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

CompletedNCT00039520

Fox Chase Cancer CenterBreast Cancer

Start: 2002-01-31End: 2008-07-31Updated: 2014-05-06

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

TerminatedNCT00062023

M.D. Anderson Cancer CenterColorectal Cancer

Start: 2003-06-30End: 2006-05-31Updated: 2012-07-30

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

CompletedNCT00068419

Children's Oncology GroupDesmoid Tumor

Start: 2004-02-29End: 2010-04-26Updated: 2020-02-19

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

CompletedNCT00335504

National Cancer Institute (NCI)Colon Cancer, Precancerous Condition, Rectal Cancer

Start: 2006-03-31End: 2009-04-30Updated: 2017-02-15

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

CompletedNCT00368927

National Cancer Institute (NCI)Precancerous Condition, Stage I Non-small Cell Lung Cancer, Tobacco Use Disorder

Start: 2006-08-31End: 2010-12-31Updated: 2014-05-23

Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

TerminatedNCT00392665

Massachusetts General HospitalSquamous Cell Carcinoma of the Head and Neck (SCCHN)

Start: 2006-10-31End: 2013-12-31Updated: 2017-04-13

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

CompletedNCT00755976

Cancer Trials IrelandMelanoma (Skin)

Start: 2007-08-31End: 2010-05-31Updated: 2014-12-31

Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma

CompletedNCT00841204

National Cancer Institute (NCI)Precancerous Condition

Start: 2009-02-28End: 2011-02-28Updated: 2017-12-26

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

CompletedNCT01187901

University of UtahAdenomatous Polyposis Coli

Start: 2010-04-30End: 2014-07-31Updated: 2016-06-17

Urinary Biomarker Study With Sulindac and Difluoromethylornithine

WithdrawnNCT01636128

Cancer Prevention Pharmaceuticals, Inc.Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms

Start: 2014-03-31End: 2016-04-30Updated: 2014-07-30

NSAID Effects on Clinical and Imaging Breast Biomarkers

CompletedNCT01761877

Stony Brook UniversityCancer, Hypertension, Inflammation +1

Start: 2012-12-31End: 2019-03-11Updated: 2023-02-10

Sulindac for Patients With AML

WithdrawnNCT01843179

Massachusetts General HospitalAcute Myeloid Leukemia

Start: 2014-01-31End: 2014-01-31Updated: 2017-02-17

Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer

TerminatedNCT01856322

National Cancer Institute (NCI)Colorectal Adenocarcinoma, Colorectal Cancer, Liver Metastasis

Start: 2013-04-30End: 2015-01-31Updated: 2015-10-23

Phase 3

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

CompletedNCT00118365

National Cancer Institute (NCI)Precancerous Condition

Start: 1998-07-31End: 2008-08-31Updated: 2015-01-22

Unknown Phase

Sulindac and Plant Compounds in Preventing Colon Cancer

TerminatedNCT00003365

University of Medicine and Dentistry of New JerseyColorectal Cancer

Start: 1996-08-31End: 2006-07-31Updated: 2011-01-27

The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon

TerminatedNCT00176618

University of Medicine and Dentistry of New JerseyAberrant Crypt Foci

Start: 2004-04-30End: 2007-06-30Target: 60Updated: 2009-12-11

A Randomized Study of Sulindac in Oral Premalignant Lesions

CompletedNCT00299195

Memorial Sloan Kettering Cancer CenterBenign Neoplasms, Leukoplakia, Oral

Start: 2006-02-23End: 2020-01-06Updated: 2020-11-19

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

CompletedNCT00343629

Mayo ClinicUnspecified Adult Solid Tumor, Protocol Specific

Start: 2006-04-30End: 2007-10-31Target: 28Updated: 2015-04-28

Related Papers

Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis

Gut2022-05-3020 citations

Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer.

2022-01-186 citations

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis

JAMA Oncology2018-02-0877 citations

Abstract LB-074: Regression of duodenal neoplasia in familial adenomatous polyposis patients using COX and EGFR inhibition: A randomized placebo-controlled trial

Cancer Research2016-07-15